Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel lymph node mapping for primary breast cancer.

Lori L Wilson1, Armando E Giuliano

  • 1Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at St. John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA.

Current Oncology Reports
|December 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Author Reflections: Evolving Axillary Management in Young Women with Breast Cancer.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB)-De-escalation of Axillary Surgery and Increased Use of Radiation.

Annals of surgical oncology·2026
Same author

Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.

Annals of surgical oncology·2026
Same author

Functional modules predict cancer-relevant genetic interactions in mammalian cells.

bioRxiv : the preprint server for biology·2025
Same author

PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA.

Cancer research·2025
Same author

ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.

Annals of surgical oncology·2025

Sentinel lymph node dissection (SLND) accurately assesses breast cancer axillary node status, offering a less invasive alternative to axillary lymph node dissection (ALND). This method improves patient outcomes with minimal morbidity.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Breast Cancer Research

Background:

  • Axillary lymph node status is crucial for breast cancer staging and survival.
  • Axillary lymph node dissection (ALND) has been the standard for operable breast cancer.
  • Assessing axillary lymph node involvement is critical for treatment planning.

Purpose of the Study:

  • To review the current status of sentinel lymph node dissection (SLND) in primary breast cancer.
  • To discuss the future directions and advancements in SLND techniques.
  • To highlight SLND as an accurate and less morbid alternative to ALND.

Main Methods:

  • Review of well-designed studies on sentinel lymph node dissection (SLND).
  • Comparison of SLND accuracy and morbidity versus traditional axillary lymph node dissection (ALND).

Related Experiment Videos

  • Analysis of the role of SLND in staging and regional control for breast cancer patients.

    • Main Results:

    • Sentinel lymph node dissection (SLND) is highly accurate in determining axillary nodal status.
    • SLND offers significantly lower morbidity compared to standard axillary lymph node dissection (ALND).
    • SLND has been validated as an effective method for staging primary breast cancer.

    Conclusions:

    • Sentinel lymph node dissection (SLND) is a reliable and effective procedure for staging breast cancer.
    • SLND minimizes surgical morbidity while maintaining high accuracy in axillary node assessment.
    • The adoption of SLND represents a significant advancement in breast cancer surgical care.